ring finger protein 138 pseudogene 1Genealiases: []
Q-omics provides the consensus-scored RNF138P1 profile across patient tissues and cancer cell-line models. RNF138P1 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in LUAD. Among the 18 cancer types available for tumor–normal comparison, RNF138P1 is differentially expressed in 11, with the highest sampling consensus in THCA. Additionally, RNF138P1 RNA expression shows 13,920 significant gene co-expression associations, with the highest sampling consensus in SARC. Together, these results highlight LUAD, THCA, and SARC as cancer lineages where RNF138P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RNF138P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RNF138P1 survival associations across molecular data types. RNF138P1 RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RNF138P1 RNA expression–survival associations across cancer types. High RNF138P1 expression shows unfavorable associations in MESO, KICH and ACC, but favorable associations in LUAD, READ and UCS. The LUAD Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .001). Together, the overview and detailed table identify LUAD as the clearest survival context for RNF138P1 RNA expression.
This table summarizes RNF138P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 11. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for RNF138P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RNF138P1 shows lower tumor expression in THCA, KICH, BRCA and UCEC and higher tumor expression in LIHC and KIRC. The THCA box plot shows higher RNF138P1 RNA expression in normal versus tumor tissue (log2 FC = −0.431, t-test p < 0.001).
This table shows molecular features associated with RNF138P1 in patient tissues and cancer cell lines. In patient samples, RNF138P1 shows the broadest associations at the RNA and protein expression levels, with SARC recurring as the lineage with the largest associated feature set.
